ArticleTranslational andrology and urology2022
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD
Rohan Malek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleTranslational andrology and urology2022
Rohan Malek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.